Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular collagen scaffold refers to a biomaterial or engineered structural matrix composed primarily of collagen, the most abundant protein in extracellular matrix. It provides three-dimensional support for cells, regulates cell behavior, and guides tissue regeneration by facilitating cell migration, adhesion, and differentiation. The collagen fibers within the scaffold are architecturally organized to mimic the native tissue’s mechanical properties[1][2][4][5][6]. Decellularized extracellular matrix scaffolds (often derived from animal tissues) promote host cell infiltration, modulate immune responses by favoring anti-inflammatory pathways, and support constructive remodeling for tissue repair. Such scaffolds do not function as classic drug targets (receptors, enzymes) but play an essential role in regenerative medicine, wound healing, and some pathological processes like fibrosis and cancer invasion[1][2][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular collagen scaffold.